CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 8 of 14

The Journal of Rheumatology

Briefs 281–320 of 523 CurrentRheuma has covered from this journal, newest publication first

Latest from The Journal of Rheumatology

All coverage, newest first

  1. J Rheumatol

    Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis by Baseline C-Reactive Protein Level: Post Hoc Analysis of Phase II and Phase III Clinical Trials

    Secondary analysisSpondyloarthritis & PsA

  2. J Rheumatol

    Evaluation of the Rheumatoid Arthritis Impact of Disease (RAID) Score in Assessing Rheumatoid Arthritis Activity in Teleconsultation

    Cohort studyRA

  3. J Rheumatol

    Exploring Reproductive Experiences With Women Enrolled in the International Vasculitis Pregnancy Registry

    Cohort studyVasculitis & PMR

  4. J Rheumatol

    Genetics of Neonatal Lupus Erythematosus Risk and Specific Manifestations

    Cohort studyLupus & APS

  5. J Rheumatol

    Implementation of a Clinician-led Medication Adherence Intervention Among Patients With Systemic Lupus Erythematosus

    Research articleLupus & APS

  6. J Rheumatol

    Long-Term Survival of Subcutaneous Biosimilar Tumor Necrosis Factor Inhibitors Compared to Originators: Results From a Multicenter Prospective Registry

    Cohort studyAcross diseases

  7. J Rheumatol

    Reproductive Outcomes for Women With Vasculitis

    Cohort studyVasculitis & PMR

  8. J Rheumatol

    Severe Features of Systemic Juvenile Idiopathic Arthritis in Patients With Congenital Heart Disease

    Cohort studyPediatric

  9. J Rheumatol

    Telerheumatology Shared-Care Model: Leveraging the Expertise of an Advanced Clinician Practitioner in Arthritis Care (ACPAC)-Trained Extended Role Practitioner in Rural-Remote Ontario

    Cohort studyAcross diseases

  10. J Rheumatol

    The State of Patient-Reported Outcome Measures in Rheumatology

    Cross-sectional studyAcross diseases

  11. J Rheumatol

    Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis: Association With Immune Activation

    Cross-sectional studyRA

  12. J Rheumatol

    Dose-Response Relationship Between Alcohol Consumption and Gout Risk: Do Subtypes of Alcoholic Beverages Make a Difference?

    Cohort studyGout & crystals

  13. J Rheumatol

    Evaluating Factors Associated With Telehealth Appropriateness in Outpatient Rheumatoid Arthritis Encounters Using the Encounter Appropriateness Score for You (EASY)

    Cohort studyRA

  14. J Rheumatol

    Which Educational Topics and Smartphone App Functions Are Prioritized by US Patients With Rheumatic and Musculoskeletal Diseases? A Mixed-Methods Study

    Cross-sectional studyAcross diseases

  15. J Rheumatol

    The Burden of Spine Structural Damage on Function in Patients With Axial Spondyloarthritis: Adaptation-Mediated Uncoupling?

    Cross-sectional studySpondyloarthritis & PsA

  16. J Rheumatol

    Patient Perspectives on a Decision Aid for Systemic Lupus Erythematosus: Insights and Future Considerations

    Research articleLupus & APS

  17. J Rheumatol

    Interpersonal Process of Dyadic Coping in Rheumatoid Arthritis: A Perspective From the Australian Rheumatology Association Database

    Cross-sectional studyRA

  18. J Rheumatol

    Sex-Related Differences in Dispensation of Rheumatic Medications in Older Patients With Inflammatory Arthritis: A Population-Based Study

    Cohort studyRA

  19. J Rheumatol

    Circulating Interleukin 17A and Other Inflammatory Proteins May Predict Cardiovascular Disease in Early Rheumatoid Arthritis

    Cohort studyRA

  20. J Rheumatol

    Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)

    Randomized controlled trialRA

  21. J Rheumatol

    Feasibility of Physiotherapist-Led Rheumatology Triage: A Randomized Study

    Randomized controlled trialAcross diseases

  22. J Rheumatol

    Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?

    Cohort studySpondyloarthritis & PsA

  23. J Rheumatol

    When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) Study

    Cohort studyAcross diseases

  24. J Rheumatol

    Hospitalization and Mortality Due to Infection Among Children and Adolescents With Systemic Lupus Erythematosus in the United States

    Cohort studyPediatric

  25. J Rheumatol

    School Well-Being and Academic Performance of Children With Juvenile Idiopathic Arthritis: A National Register-Based Study

    Cross-sectional studyPediatric

  26. J Rheumatol

    Association of Infant Breastfeeding and Juvenile Spondyloarthritis: A Case-Control Study

    Case-control studyPediatric

  27. J Rheumatol

    Pan American League of Associations for Rheumatology Recommendations for the Treatment of Psoriatic Arthritis

    Guideline or statementSpondyloarthritis & PsA

  28. J Rheumatol

    Patients With Psoriatic Arthritis–Related Enthesitis and Persistence on Tofacitinib Under Real-World Conditions

    Cohort studySpondyloarthritis & PsA

  29. J Rheumatol

    Phase-Specific Healthcare Costs Associated With Giant Cell Arteritis in Ontario, Canada

    Cohort studyVasculitis & PMR

  30. J Rheumatol

    Prevalence, Predictors, and Prognosis of Serious Infections in Takayasu Arteritis: A Cohort Study

    Cohort studyVasculitis & PMR

  31. J Rheumatol

    Increased Interferon Signaling in Vaginal Tissue of Patients With Primary Sjögren Syndrome

    Mechanistic studySjögren's & overlap

  32. J Rheumatol

    Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus

    Cohort studyLupus & APS

  33. J Rheumatol

    Maximal Exercise Tolerance, Objective Trunk Strength, and Mobility Measurements in Axial Spondyloarthritis

    Cross-sectional studySpondyloarthritis & PsA

  34. J Rheumatol

    Defining the Minimal Important Change and Meaningful Change Value of the Disease Activity Index for Psoriatic Arthritis: A Chinese Longitudinal Study

    Cohort studySpondyloarthritis & PsA

  35. J Rheumatol

    Perceived Access to Healthcare of Indigenous Peoples in Canada With Rheumatoid Arthritis and Their First-Degree Relatives

    Cross-sectional studyRA

  36. J Rheumatol

    Immune Checkpoint Inhibitor–Associated Remitting Seronegative Symmetrical Synovitis With Pitting Edema: Description of a New Entity by CanRIO

    Cohort study

  37. J Rheumatol

    Factors Associated With an Electronic Health Record–Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease

    Cohort studyAcross diseases

  38. J Rheumatol

    Long-Term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis in Japan: 10-Year Analysis of the Real-World TRUST Study

    Cohort studyLupus & APS

  39. J Rheumatol

    Treatment Patterns and Effectiveness of Tofacitinib in Patients Initiating Therapy for Rheumatoid Arthritis: Results From the CorEvitas Rheumatoid Arthritis Registry

    Cohort studyRA

  40. J Rheumatol

    Understanding the Employment Landscape in People With Systemic Sclerosis

    Cross-sectional studySystemic sclerosis

All 523 Briefs in ExploreShowing Briefs 281–320 of 523, newest first